Can-Fite BioPharma American Depositary Shares
CANF
11 hedge funds and large institutions have $5.35M invested in Can-Fite BioPharma American Depositary Shares in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
236% more capital invested
Capital invested by funds: $1.59M → $5.35M (+$3.76M)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
38% more funds holding
Funds holding: 8 → 11 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$2.5M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.26M |
| 3 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$160K |
| 4 |
Morgan Stanley
New York
|
+$82.9K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$22.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$29K |
| 2 |
WWMSC
Wagner Wealth Management (South Carolina)
Greenville,
South Carolina
|
-$5.52K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AFM
1
Anson Funds Management
Dallas,
Texas
| $1.96M | +$2.5M | +453 | New |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $1.77M | +$2.26M | +409 | New |
|
|
TAM
3
Taylor Asset Management
Toronto,
Ontario, Canada
| $1.06M | – | – | – |
|
|
MIH
4
Meitav Investment House
Bene-Beraq,
Israel
| $352K | +$160K | +29 | +56% |
|
|
5
Morgan Stanley
New York
| $161K | +$82.9K | +15 | +68% |
|
|
RJA
6
Raymond James & Associates
St Petersburg,
Florida
| $20K | +$5.52K | +1 | +25% |
|
|
7
Acadian Asset Management
Boston,
Massachusetts
| $15K | +$22.1K | +4 | New |
|
|
AF
8
Advisornet Financial
Minnetonka,
Minnesota
| $5K | – | – | – |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $4.32K | +$5.52K | +1 | New |
|
|
WWMSC
10
Wagner Wealth Management (South Carolina)
Greenville,
South Carolina
| $4K | -$5.52K | -1 | -50% |
|
|
PVH
11
Psagot Value Holdings
Tel Aviv,
Israel
| $4K | – | – | – |
|
|
VF
12
Virtu Financial
New York
| – | -$29K | -7 | Closed |
|
|
13
UBS Group
Zurich,
Switzerland
| – | -$1K | – | – |
|
CANF Hedge Fund Activity: Q1 2018 in Review
11 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q1 2018, worth a combined $5.35M — up 236% from $1.59M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CANF positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $2.5M. The largest seller was Virtu Financial, exiting entirely with an estimated $29K sold.
- 11 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q1 2018, up from 8 in Q4 2017.
- Funds reported $5.35M of Can-Fite BioPharma American Depositary Shares stock for Q1 2018, up 236% quarter-over-quarter.
- 4 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q1 2018 and 1 closed out, a net change of +3 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q1 2018 was Anson Funds Management, an estimated $2.5M added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q1 2018 was Virtu Financial, an estimated $29K sold.
Based on aggregated 13F filings for Q1 2018.